As of 2026-03-13, the Fair Value of Neogenomics Inc (NEO) is -4.17 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 7.98 USD, the upside of Neogenomics Inc is -152.31%.
With the market price of 7.98 USD and our fair value calculation, Neogenomics Inc (NEO) is not a good investment. Investing in NEO stocks now will result in a potential loss of 152.31%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | -8.30 | -144.30 | -87.97 | -78.73 | -108.03 | -85.46 |
| YoY growth | -297.62% | -1,638.55% | 39.04% | 10.51% | -37.22% | -384.77% |
| Market Cap (mil) | 1,032.53 |
| P/E | |
| Forward P/E |
| EPS | -0.83 |
| Avg earnings growth rate | -384.77% |
| TTM earnings | -108.03 |